StreetInsider.com News Articles

Milestone Scientific adds two directors, shifts chair to executive role

Thu, 25 Jun 2026 09:04:25 -0400

Milestone Scientific Inc. (NYSE: MLSS) announced changes to its board of directors, including the appointment of two independent directors and a leadership transition at the board level.

Benedetta I. Casamento has moved from Chair of the Board to Executive Chair, a role in which she will work with the management team on strategic guidance and execution of company objectives.

Greg Shilling and Kelly Ann Ulto have been appointed as independent board members. Shilling has more than 30 years of experience in healthcare technology, software, artificial intelligence and cybersecurity, and currently serves as Partner and General Manager of 121G and 10Bridge. He previously

Milestone Scientific adds two directors, shifts chair to executive role

Thu, 25 Jun 2026 09:04:25 -0400

Milestone Scientific Inc. (NYSE: MLSS) announced changes to its board of directors, including the appointment of two independent directors and a leadership transition at the board level.

Benedetta I. Casamento has moved from Chair of the Board to Executive Chair, a role in which she will work with the management team on strategic guidance and execution of company objectives.

Milestone Scientific Strengthens Board to Support Next Phase of Growth

Thu, 25 Jun 2026 09:00:00 -0400

Appoints Two Independent Directors with Deep Healthcare, Technology and Financial Expertise Chair of the Board Transitions to Executive Chair to Drive Strategic Execution

ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced a series of strategic governance initiatives designed to support the Company’s continued evolution and long-term growth. These actions include strengthening the Board of Directors with two highly experienced independent directors, transitioning Board leadership to support closer strategic execution and aligning with the Company's founder through a

Milestone Scientific Strengthens Board to Support Next Phase of Growth

Thu, 25 Jun 2026 09:00:00 -0400

Appoints Two Independent Directors with Deep Healthcare, Technology and Financial Expertise Chair of the Board Transitions to Executive Chair to Drive Strategic Execution

Form 8-K MILESTONE SCIENTIFIC For: Apr 30

Thu, 25 Jun 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20260625/26689105.html

Form 8-K MILESTONE SCIENTIFIC For: Apr 30

Thu, 25 Jun 2026 09:00:00 -0400

si-local-file:///var/storage/secattach/20260625/26689105.html

Form DEF 14A MILESTONE SCIENTIFIC For: Jun 22

Mon, 22 Jun 2026 14:27:00 -0400

si-local-file:///var/storage/secattach/20260622/26672367.html

Form DEF 14A MILESTONE SCIENTIFIC For: Jun 22

Mon, 22 Jun 2026 14:27:00 -0400

si-local-file:///var/storage/secattach/20260622/26672367.html

Form PRER14A MILESTONE SCIENTIFIC

Wed, 10 Jun 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260610/26629212.html

Form PRER14A MILESTONE SCIENTIFIC

Wed, 10 Jun 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260610/26629212.html

Form EFFECT MILESTONE SCIENTIFIC

Wed, 10 Jun 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260610/26626131.html

Form EFFECT MILESTONE SCIENTIFIC

Wed, 10 Jun 2026 06:03:00 -0400

si-local-file:///var/storage/secattach/20260610/26626131.html

Form 424B1 MILESTONE SCIENTIFIC

Tue, 09 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260609/26623749.html

Form 424B1 MILESTONE SCIENTIFIC

Tue, 09 Jun 2026 16:11:00 -0400

si-local-file:///var/storage/secattach/20260609/26623749.html

Form PRE 14A MILESTONE SCIENTIFIC For: Jun 05

Fri, 05 Jun 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260605/26612279.html

Form PRE 14A MILESTONE SCIENTIFIC For: Jun 05

Fri, 05 Jun 2026 17:25:00 -0400

si-local-file:///var/storage/secattach/20260605/26612279.html

Form S-3 MILESTONE SCIENTIFIC

Tue, 02 Jun 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260602/26592122.html

Form S-3 MILESTONE SCIENTIFIC

Tue, 02 Jun 2026 16:27:00 -0400

si-local-file:///var/storage/secattach/20260602/26592122.html

Milestone Scientific (MLSS) Reiterated at Speculative Buy by Benchmark After Q1 Results

Tue, 19 May 2026 07:45:02 -0400

Benchmark analyst Bruce Jackson reiterated a Speculative Buy rating and $1.00 price target on Milestone Scientific (NYSE: MLSS).

The analyst commented, "Milestone Scientific hosted a 1Q business update call. Revenue of $2.2 million was roughly in line with our estimate of $2.3 million. Operating cash flow was $0.1 million for the quarter as the company showed tight expense control, ending 1Q with $1.2 million in cash. Management maintained the 2026 revenue guidance range of $9.8-10.2 million, which represents growth of more than 10% year-over-year. Within that, they expect CompuFlo revenue to grow at an even greater pace over the remainder of

Milestone Scientific Reports Financial Results for First Quarter 2026

Thu, 14 May 2026 07:30:00 -0400